Atossa Therapeutics
ATOS
ATOS
89 hedge funds and large institutions have $225M invested in Atossa Therapeutics in 2021 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
17% more call options, than puts
Call options by funds: $84M | Put options by funds: $71.8M
14.45% more ownership
Funds ownership: 15.13% → 29.58% (+14%)
Holders
89
Holding in Top 10
1
Calls
$84M
Puts
$71.8M
Top Buyers
| 1 | +$46.9M | |
| 2 | +$16.3M | |
| 3 | +$16.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$12.8M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$11.7M |
Top Sellers
| 1 | -$6.97M | |
| 2 | -$1.6M | |
| 3 | -$912K | |
| 4 |
Barclays
London,
United Kingdom
|
-$268K |
| 5 |
Capstone Investment Advisors
New York
|
-$108K |